Cardiovascular molecular MR imaging.

H J Lamb, R W van der Meer, A de Roos, J J Bax

Journal: European journal of nuclear medicine and molecular imaging 2007;34 Suppl 1(Suppl 1):S99-104

PMID: 17505824

Abstract

INTRODUCTION

Cardiovascular molecular imaging is a rapidly evolving field of research, aiming to image and quantify molecular and cellular targets in vivo. MR imaging has some inherent properties that make it very suitable for cardiovascular molecular imaging. Until now, only a limited number of studies have been published on cardiovascular molecular imaging using MR imaging.

REVIEW

In the current review, MR techniques that have already shown potential are discussed. Metabolic MR imaging can be performed by (31)P-MR spectroscopy, (23)Na MR spectroscopy and (1)H-MR spectroscopy; some examples are shown. Furthermore, a concise overview is given of several aspecific and specific contrast agents for cardiovascular molecular MR imaging, such as gadolinium-based contrast agents, iron oxide MR contrast agents and fibrin-targeted MR contrast agents.

CONCLUSION

We expect that in the next decade currently promising MR molecular imaging agents will be introduced into the clinical arena to guide diagnosis and therapy of cardiovascular disease.

Address: Department of Radiology, C2S, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.